image description

Tag: Kenneth Farber

Help Kick Off the ManyOne Can. Walk with Us to Cure Lupus

July 30, 2020 Click here to view the replay of our recent  Kickoff to the 2020 ManyOne Can Walk with Us to Cure Lupus presented by GSK.  Hosted by Lupus Research Alliance’s President Ken Farber, this FUNd-raising Zoom webcast featured seasoned Walk Captains who gave lots of great ideas for team building and FUNdraising, in […] Read More

Lupus and COVID-19:What You Need to Know Webcast on Video

April 3, 2020 The Lupus Research Alliance (LRA) hosted a live webcast April 2, 2020 on COVID-19 for people with lupus that you won’t want to miss – so click here to view the full video recording. The webast addressed the most frequently asked questions doctors are hearing from people with lupus, put the hydroxychloroquine […] Read More

COVID-19 Update: A Message from LRA President & CEO

March 18, 2020 Dear Friends, Your well-being is the utmost priority for all of us at the Lupus Research Alliance (LRA). We are consulting with top lupus clinicians and scientists in monitoring the situation posed by the spread of the SARS coronavirus (SARS-CoV-2) often referred to as COVID-19, across the world and committed to doing […] Read More

The Lupus Research Alliance Partners with the National Kidney Foundation to Offer Course to Healthcare Professionals

November 12, 2019 The Lupus Research Alliance (LRA) is pleased to announce a new collaboration with the National Kidney Foundation (NKF) on a free course for healthcare professionals about ways to better diagnose, monitor and treat patients with systemic lupus erythematosus (SLE) and lupus nephritis. The online course is critically important because as the community […] Read More

New Study Partly Funded by LRA Reveals Novel Lupus Drug Targets

NEW YORK, NY – May 29. Researchers partly funded by the Lupus Research Alliance (LRA) have found possible new targets for drugs to treat lupus after snapping the first close-up of a molecule that promotes inflammation. The molecule that Target Identification in Lupus (TIL) grant recipient Dr. Roger Greenberg at University of Pennsylvania and Dr. […] Read More

Benlysta Approved for Children 5-Years and Up

April 26, 2019 We are very pleased to share news from GlaxoSmithKline (GSK) that intravenous Benlysta (belimumab) was approved by the U.S. Food and Drug Administration to treat children with lupus who are five years old or above. The approval was based on data from the ‘PLUTO’ study testing over one year the effectiveness and […] Read More

Lupus Research Alliance and National Minority Quality Forum Release Recommendations to Advance New Lupus Treatments by Increasing Diversity in Clinical Trial Participation

NEW YORK, NY. March 14, 2019.  The Lupus Research Alliance (LRA) and the National Minority Quality Forum (NMQF) today released the insightful report, Addressing the Challenges of Clinical Research Participation Among Populations Disproportionately Impacted by Lupus. The report presents findings and actionable recommendations ranging in scope that can be implemented by any individual or group seeking […] Read More